Sphingolipids as targets for inhalation treatment of cystic fibrosis. (2018)

First Author: Becker KA
Attributed to:  Newcastle Confidence in Concept 2016 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.addr.2018.04.015

PubMed Identifier: 29698625

Publication URI: http://europepmc.org/abstract/MED/29698625

Type: Journal Article/Review

Volume: 133

Parent Publication: Advanced drug delivery reviews

ISSN: 0169-409X